ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

JORGE ACEVEDO-CRESPO M.D., F.C.C.P.

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,554Medicare Part D Prescriptions Filled, Including Refills

Rank: 92 out of 1290

$709K Total Retail Price of All Prescriptions

Rank: 103 out of 1290

282 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 282 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

6% of this provider’s 282 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 7,098 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

47% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
METFORMIN HCL 325 264 1 10
SPIRIVA 315 263 2 75
AMLODIPINE BESYLATE 280 235 3 3
CRESTOR 268 204 4 17
NEXIUM 248 214 5 34
ADVAIR DISKUS 242 175 6 37
JANUVIA 234 206 7 82
METOPROLOL TARTRATE 230 213 8 7
CLOPIDOGREL 223 201 9 24
OMEPRAZOLE 216 178 10 2
PROAIR HFA 214 162 11 73
FUROSEMIDE 198 164 12 9
PLAVIX 183 163 13 32
POTASSIUM CHLORIDE 181 151 14 35
PANTOPRAZOLE SODIUM 163 144 15 48
DIOVAN HCT 157 117 16 112
LEVOTHYROXINE SODIUM 156 121 17 4
SIMVASTATIN 151 108 18 1
ENALAPRIL MALEATE 150 116 19 62
SINGULAIR 129 92 20 85
DIOVAN 111 103 21 53
LIDODERM 98 71 22 113
NIFEDIPINE ER 96 60 23 110
NITROGLYCERIN PATCH 95 87 24 212
DONEPEZIL HCL 89 89 25 13
GLIPIZIDE 88 81 26 81
NAMENDA 86 82 27 27
ESCITALOPRAM OXALATE 83 79 28 63
CARVEDILOL 79 55 29 12
ZOLPIDEM TARTRATE 71 62 30 15
ATENOLOL 71 55 30 18
LISINOPRIL 70 54 32 5
DIGOXIN 70 62 32 51
GABAPENTIN 64 47 34 8
ALLOPURINOL 61 41 35 60
BENAZEPRIL HCL 55 44 36 140
MONTELUKAST SODIUM 54 40 37 189
LYRICA 53 41 38 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.